Parenteral Drugs (India) (BOM:524689) Total Liabilities : ₹13,081.42 Mil (As of Mar. 2022)

View and export this data going back to 2001. Start your Free Trial

What is Parenteral Drugs (India) Total Liabilities?

Parenteral Drugs (India)'s Total Liabilities for the quarter that ended in Mar. 2022 was ₹13,081.42 Mil.

Parenteral Drugs (India)'s quarterly Total Liabilities declined from Sep. 2021 (₹13,257.00 Mil) to Dec. 2021 (₹0.00 Mil) but then increased from Dec. 2021 (₹0.00 Mil) to Mar. 2022 (₹13,081.42 Mil).

Parenteral Drugs (India)'s annual Total Liabilities increased from Mar. 2020 (₹11,130.34 Mil) to Mar. 2021 (₹12,509.58 Mil) and increased from Mar. 2021 (₹12,509.58 Mil) to Mar. 2022 (₹13,081.42 Mil).

Parenteral Drugs (India) Total Liabilities Historical Data

The historical data trend for Parenteral Drugs (India)'s Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parenteral Drugs (India) Total Liabilities Chart

Parenteral Drugs (India) Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Total Liabilities

Get a 7-Day Free Trial

10,265.76

9,873.68

11,130.34

12,509.58

13,081.42

Parenteral Drugs (India) Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Total Liabilities	Get a 7-Day Free Trial															12,509.58	-	13,257.00	-	13,081.42

Parenteral Drugs (India) Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Parenteral Drugs (India)'s Total Liabilities for the fiscal year that ended in Mar. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12008.375	+	(1071.994	+	1.05
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	13,081.42

Total Liabilities	=	Total Assets (A: Mar. 2022 )	-	Total Equity (A: Mar. 2022 )
	=	4842.338	-	-8239.081
	=	13,081.42

Parenteral Drugs (India)'s Total Liabilities for the quarter that ended in Mar. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12008.375	+	(1071.994	+	1.05
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	13,081.42

Total Liabilities	=	Total Assets (Q: Mar. 2022 )	-	Total Equity (Q: Mar. 2022 )
	=	4842.338	-	-8239.081
	=	13,081.42

Parenteral Drugs (India) Total Liabilities Related Terms

Thank you for viewing the detailed overview of Parenteral Drugs (India)'s Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Parenteral Drugs (India) (BOM:524689) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parenteral Drugs (India) Ltd (BOM:524689) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001

Website

http://www.pdindia.com

Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.

Parenteral Drugs (India) (BOM:524689) Headlines

No Headlines